|
|
|
|
Direct Cost |
Indirect Cost |
|
261201300390P-0-0-1 |
Cancer Surveillance Trend Estimates from Multiple Data Sets |
UNIVERSITY OF PENNSYLVANIA |
NCI |
|
|
$40,138 |
268200800003C-9-0-1 |
RANDOMIZED CLINICAL TRIAL OF GENOTYPE GUIDED DOSING OF WARFARIN THERAPY |
UNIVERSITY OF PENNSYLVANIA |
NHLBI |
|
|
$437,031 |
268201200041C-1-0-1 |
R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH) |
UNIVERSITY OF PENNSYLVANIA |
NHLBI |
|
|
$3,227,133 |
272200900038C-4-0-7 |
Bioinformatics Resource Center |
UNIVERSITY OF PENNSYLVANIA |
NIAID |
|
|
$673,819 |
275201300020I-0-27500001-1 |
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE |
UNIVERSITY OF PENNSYLVANIA |
NICHD |
|
|
$59,540 |
275201300020I-0-27500002-1 |
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE |
UNIVERSITY OF PENNSYLVANIA |
NICHD |
|
|
$896,346 |
1F30AG044078-01A1 |
ChR2 delivery to the neuroretina to circumvent age-related neurodegeneration |
UNIVERSITY OF PENNSYLVANIA |
NIA |
$28,764 |
|
$28,764 |
1F30AG044995-01A1 |
Cell-Intrinsic and Extrinsic Factors in Stem Cell Aging |
UNIVERSITY OF PENNSYLVANIA |
NIA |
$44,946 |
|
$44,946 |
1F30CA174133-01 |
Mutant p53 has gain-of-function mechanisms to mediate tumor invasion |
UNIVERSITY OF PENNSYLVANIA |
NCI |
$28,764 |
|
$28,764 |
1F30CA177106-01 |
HIF-2alpha mediated mitophagy and lipogenesis in clear cell renal cell carcinoma |
UNIVERSITY OF PENNSYLVANIA |
NCI |
$42,232 |
|
$42,232 |
1F30CA177123-01 |
Transcriptional Coregulation in Pancreatic Adenocarcinoma Progression |
UNIVERSITY OF PENNSYLVANIA |
NCI |
$42,232 |
|
$42,232 |
1F30CA177190-01 |
Cellular mechanisms of transcriptional regulation near DNA double-strand breaks |
UNIVERSITY OF PENNSYLVANIA |
NCI |
$28,673 |
|
$28,673 |
1F30CA180601-01 |
The Role of p120ctn in Pancreatic Ductal Morphogenesis and Adenocarcinoma |
UNIVERSITY OF PENNSYLVANIA |
NCI |
$45,637 |
|
$45,637 |
1F30DK100123-01 |
Metabolic defects in mice with adipocyte-specific deletion of Akt2 |
UNIVERSITY OF PENNSYLVANIA |
NIDDK |
$28,764 |
|
$28,764 |
1F30HL119030-01 |
Inflammation promoting respiratory tract infection |
UNIVERSITY OF PENNSYLVANIA |
NHLBI |
$44,946 |
|
$44,946 |
1F30HL120487-01 |
Reversal of Direct FXa Inhibitors Using Zymogen-Like Variants of FXa |
UNIVERSITY OF PENNSYLVANIA |
NHLBI |
$42,232 |
|
$42,232 |
1F31CA174211-01 |
Role of microRNA-124 in counteracting glioblastoma adaptation to cellular stress |
UNIVERSITY OF PENNSYLVANIA |
NCI |
$42,232 |
|
$42,232 |
1F31CA177086-01 |
Role of Non-Core RAG1 in DSB Repair, Cell Survival, and Cell Cycle Progression |
UNIVERSITY OF PENNSYLVANIA |
NCI |
$42,232 |
|
$42,232 |
1F31CA177092-01 |
Cyclin D3 and DNA double strand breaks: genome stability and lymphomagenesis |
UNIVERSITY OF PENNSYLVANIA |
NCI |
$42,232 |
|
$42,232 |
1F31CA177182-01 |
P21-activated kinase 1 and 2 as therapeutic targets of the NF1 microenvironment |
UNIVERSITY OF PENNSYLVANIA |
NCI |
$28,764 |
|
$28,764 |